The European synthetic biology market is anticipated to grow at the CAGR of 31.8% during the forecast period. Major European economies contributing in the market are the UK, Germany and France. Various biotech companies are working in the field of synthetic biology in these economies. Additionally, several associations have been established in the region for providing better environment in research and development. Number of universities such as the Cambridge University, have also involved in various studies and research in the field of synthetic biology in collaborations of government or companies or both. Due to this, factor a positive environment for the research and development in synthetic biology has been created in the region.

Visit for Global Synthetic Biology Market Report at: https://www.omrglobal.com/industry-reports/synthetic-biology-market-size

Furthermore, technological advancements in the life science sector have resulted in increased speed and reduced cost of DNA amalgamation. This enables researchers to design and integrate adjusted bacterial chromosomes that can be utilized as a part of the generation of cutting-edge biofuels, bio-items, sustainable chemicals, and others. The advancements in modern engineering have enabled scientists to build new sequences of DNA. 

The European synthetic biology market is segmented on the basis of product, technology, and applications. Based on the product, the market is segmented into enabling product, core product, and enabled product. Core product includes synthetic genes, synthetic cells, synthetic DNA, chassis organisms and xeno nucleic acid (XNA), and are expected to hold a significant share in the market owing to extensive use of core products in R&D. Based on technology, the market is segmented into, and gene synthesis & sequencing, genome engineering, bioinformatics, and others. Based on application, the market is segmented into medical application, industrial application, food & agriculture, and environmental applications.

The report study of the European synthetic biology industry includes the competitive analysis of various players as well as the trend followed by them to sustain in the market. Some of the players operating in the market include Twist Bioscience Corp., Merck KGaA, GenScript Biotech Corp., Thermo Fisher Scientific Inc., Amyris Inc., Codexis Inc, Ginkgo Bioworks, and many others. These players are focusing on agreements along with new product launches for expanding their business. For instance, in 2017, Ginkgo Bioworks completed its acquisition of Gen9, a Cambridge based gene synthesis company. With this acquisition, the company aimed at strengthening its market reach in different geographies.

Research Methodology

The market study of the European synthetic biology is incorporated by extensive primary and secondary research conducted by the research team at OMR. Secondary research has been conducted to refine the available data to breakdown the market in various segments, derive total market size, market forecast, and growth rate. Different approaches have been worked on to derive the market value and market growth rate. Our team collects facts and data related to the market from different geography to provide a better regional outlook. In the report, the country-level analysis is provided by analyzing various regional players, regional tax laws and policies, consumer behavior and macro-economic factors. Numbers extracted from secondary research have been authenticated by conducting proper primary research. It includes tracking down key people from the industry and interviewing them to validate the data. This enables our analyst to derive the closest possible figures without any major deviations in the actual number. Our analysts try to contact as many executives, managers, key opinion leaders, and industry experts. Primary research brings authenticity in our reports.

Secondary Sources Include

• Financial reports of companies involved in the market.
• Whitepapers, research-papers, and news blogs.
• Company websites and their product catalog.

The report is intended for pharmaceutical companies, drug manufacturers, biotechnology companies, chemical and biofuel industry, academic and government research institutes, food and agriculture industries, potential investors and venture capitalists, and other market participants for overall market analysis and competitive analysis. The report provides an in-depth analysis of market size, products offered by the company, and future market opportunities. The report will serve as a source for a 360-degree analysis of the market thoroughly delivering insights into the market for making better business decisions.

Market Segmentation

1. European Synthetic Biology Market Research and Analysis by Product.

2. European Synthetic Biology Market Research and Analysis by Technology. 

3. European Synthetic Biology Market Research and Analysis by Application.

The Report Covers

• Comprehensive research methodology of the European synthetic biology market.
• This report also includes a detailed and extensive market overview with key analyst insights.
• An exhaustive analysis of macro and micro factors influencing the market guided by key recommendations.
• Analysis of regional regulations and other government policies impacting the European synthetic biology market.
• Insights about market determinants which are stimulating the European synthetic biology market.
• Detailed and extensive market segments with regional distribution of forecasted revenues.
• Extensive profiles and recent developments of market players.